|
 |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
Neurotech to initiate phase I clinical testing of AAD-2004
 |
|
| Neurotech Pharmaceuticals, has begun dosing in the phase I clinical testing of AAD-2004 which is drug to remove free radicals and PGE2, the mediators of nerve injury in Alzheimer's disease, Parkinson's, and amyotrophic lateral sclerosis |
|
 |
|
|
| |
|
|
| |
| Sanofi's Teriflunomide treats multiple sclerosis
|
|
| French drugmaker Sanofi-aventis announced that the investigational oral drug teriflunomide significantly reduced annualized relapse rate at 2 years versus placebo in patients with relapsing multiple sclerosis. |
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| More |
